They showed that apoptosis of the Gal-3-silenced AML cell line increased in the presence of cytotoxic drugs, and that the protective effect of hBM-MSCs against cytotoxic drugs was diminished by Gal-3 silencing in the AML cell line [107]. The gene discussed is LGALS3; the disease is acute myeloid leukemia.